Cigna Denied Cancer Treatment: Appeal Steps That Work

Why Cigna Denies Cancer Treatment Claims

A cancer diagnosis is already one of the most difficult experiences a person can face. Receiving a denial from Cigna for the treatment your oncologist recommends adds a layer of bureaucratic cruelty that no patient should have to endure. Cigna denies cancer treatment claims for a range of reasons, and understanding the specific basis for the denial is essential to crafting an appeal that works.

medical necessity disputes using Cigna's coverage policies. Cigna maintains its own medical coverage policies that specify the clinical criteria for cancer treatment authorization. These policies may be more restrictive than the NCCN (National Comprehensive Cancer Network) Clinical Practice Guidelines that represent the standard of care in oncology. When Cigna's criteria diverge from NCCN recommendations, patients are caught in the gap -- their oncologist recommends a treatment that NCCN supports, but Cigna denies it because it does not meet Cigna's narrower criteria.

Off-label drug denials. Off-label prescribing is standard practice in oncology. Many cancer drugs are FDA-approved for one cancer type but have demonstrated efficacy in other cancers through clinical trials and real-world evidence. Cigna frequently denies off-label cancer drug use, classifying it as experimental even when the NCCN Compendium lists the use as recommended or appropriate. These denials conflict with both clinical practice and many state off-label coverage mandates.

Experimental or investigational classification. Cigna classifies newer cancer treatments as experimental or investigational, including novel immunotherapy combinations, targeted therapies for uncommon molecular subtypes, and treatments still under investigation in clinical trials. While the ACA requires coverage of routine patient care costs in qualifying clinical trials, Cigna may deny the investigational drug itself or dispute which costs qualify as routine.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization delays and denials. Cigna requires prior authorization for cancer treatments, and the authorization process can introduce delays that are dangerous for cancer patients. Cigna's prior authorization reviewers may deny requests based on incomplete documentation, disagreement with the treatment plan, or application of Cigna's own clinical criteria rather than NCCN guidelines.

step therapy requirements. Cigna may require cancer patients to try a first-line therapy and document failure before authorizing the treatment their oncologist prescribed. In oncology, requiring a patient to fail on an inferior regimen before authorizing the optimal treatment risks disease progression, treatment resistance, and declining performance status.

Specialty pharmacy and formulary restrictions. Cigna's Express Scripts pharmacy benefit (Cigna acquired Express Scripts in 2018) may impose formulary restrictions on cancer drugs, requiring use of formulary alternatives or Cigna's specialty pharmacy. These restrictions can delay medication access and force substitution of less optimal agents.

Site of service restrictions. Cigna may deny cancer treatment at academic medical centers or specialized cancer centers, asserting that community oncology practices can provide the same care at lower cost. For patients with rare cancers, complex presentations, or cancers requiring multidisciplinary tumor board review, this restriction compromises care quality.

Common Denial Codes and Reasons

• Not medically necessary -- Cigna's reviewer determined the treatment does not meet coverage policy criteria
• Experimental or investigational -- Cigna classified the treatment as unproven
• Off-label use not supported -- The drug is prescribed outside FDA-approved indications and Cigna does not recognize the off-label use
• Prior authorization denied or not obtained -- Treatment was not pre-authorized
• step therapy required -- Cigna requires failure on a first-line agent before authorizing the recommended treatment
• Non-formulary medication -- The cancer drug is not on Cigna's Express Scripts formulary
• Out-of-network / site of service -- Treatment at a non-network or specialized cancer center was not authorized
• clinical trial cost dispute -- Cigna disputes which clinical trial costs are routine versus investigational

Your Legal Rights

ACA Essential Health Benefits

The ACA requires ACA-compliant plans to cover cancer treatment as an essential health benefit. The ACA mandates coverage of routine patient care costs in qualifying clinical trials and guarantees appeal rights and External Independent Review: Complete Guide" class="auto-link">external review. Cigna cannot categorically exclude medically necessary cancer treatment.

NCCN Guidelines as Standard of Care

The NCCN Clinical Practice Guidelines are the nationally recognized standard of care for cancer treatment. When a treatment is recommended by NCCN for a specific cancer type, stage, and molecular profile, this constitutes medical necessity. The NCCN Compendium also supports off-label cancer drug use. If Cigna's coverage policies are more restrictive than NCCN guidelines, this discrepancy is a powerful appeal argument.

State Cancer Treatment Mandates

Many states require insurers to cover off-label cancer drug use when supported by recognized compendia (NCCN, DrugDex, AHFS), provide oral chemotherapy parity (equal cost-sharing for oral and IV chemo), cover clinical trial participation, exempt cancer patients from step therapy requirements, and ensure access to specialized cancer centers. Research your state's specific protections.

erisa-protections">ERISA Protections

For employer-sponsored Cigna plans, ERISA guarantees appeal rights, access to the claims file, and a clear explanation of the denial. ERISA requires that the reviewer be qualified in the relevant medical specialty -- for cancer treatment, this means a board-certified oncologist.

Expedited Appeal Rights

Cancer treatment appeals are eligible for expedited processing under the ACA and ERISA. Cigna must decide expedited pre-service appeals within 72 hours. Always request expedited processing for cancer treatment denials.

Step-by-Step Appeal Instructions

Step 1: Request Expedited Appeal Processing

File an expedited appeal immediately. Cancer treatment delays can allow disease progression, and the 72-hour expedited timeline is designed for exactly this situation. Request expedited processing by phone and in writing simultaneously.

Step 2: Obtain the Claims File and Cigna's Coverage Policy

Request the complete claims file, the specific Cigna medical coverage policy applied, the reviewer's credentials and specialty, and the detailed denial rationale. Compare Cigna's coverage policy to the NCCN guideline for your cancer type to identify where they diverge.

Step 3: Obtain Comprehensive Oncologist Documentation

Your oncologist should provide:

• Complete cancer diagnosis with TNM staging, histology, grade, and molecular/genomic markers (ER/PR, HER2, PD-L1, EGFR, ALK, ROS1, BRAF, KRAS, NTRK, TMB, MSI, etc.)
• Complete treatment history including all prior therapies, responses, toxicities, and reasons for discontinuation
• The recommended treatment with detailed clinical rationale
• NCCN guideline citations showing the treatment is recommended (with category of evidence and consensus) for this specific cancer presentation
• If off-label: NCCN Compendium listing, DrugDex listing, or peer-reviewed evidence supporting the use
• If experimental: FDA designations (breakthrough therapy, fast track, accelerated approval), published clinical trial data, and real-world evidence
• If step therapy: why the prescribed treatment should be first-line and why the required alternative is inferior for this specific molecular profile
• Consequences of treatment delay: disease progression risk, narrowing of future treatment options, performance status decline
• If specialized center needed: the specific expertise, tumor board access, or clinical trial availability that the community setting lacks

Step 4: File the Internal Appeal

Submit the expedited appeal addressing Cigna's specific denial reason:

• If denied for medical necessity: Present NCCN guidelines and argue that Cigna's coverage policy is more restrictive than the accepted standard of care
• If denied as experimental: Present FDA designations, published data, NCCN listing, and adoption by major cancer centers
• If denied for off-label use: Present NCCN Compendium listing and applicable state off-label mandate
• If denied for step therapy: Cite NCCN guidelines recommending the prescribed treatment as preferred, and document the clinical risks of an inferior first-line agent
• If denied for site of service: Present the clinical complexity requiring specialized expertise that the community setting cannot provide

Step 5: Request a Peer-to-Peer Review

Your oncologist should request a peer-to-peer review with Cigna's oncology medical director. Insist that the reviewer be a board-certified oncologist, ideally with expertise in your specific cancer type. The peer-to-peer allows your oncologist to present the clinical nuances that medical records alone may not convey.

Step 6: Pursue External Review

If Cigna upholds the denial, file for external review immediately. An independent oncologist will evaluate the case against generally accepted standards of care, not Cigna's proprietary coverage policies. Cancer treatment denials supported by NCCN guidelines are frequently overturned at external review.

Step 7: File Regulatory Complaints

File with your state Department of Insurance through the NAIC directory. If your state has cancer treatment mandates that Cigna is not following, cite them specifically. For ERISA plans, file with the Department of Labor.

Common Mistakes to Avoid

Not requesting expedited processing. Every cancer appeal should be expedited. The 72-hour timeline exists for this exact situation.

Not comparing Cigna's policy to NCCN guidelines. Obtain Cigna's specific coverage policy and compare it criterion by criterion to the NCCN guideline. Discrepancies are your strongest appeal argument.

Accepting a non-oncologist reviewer. Cancer treatment decisions must be reviewed by qualified oncologists. Challenge the credentials of any non-oncologist reviewer.

Accepting step therapy without challenge. Step therapy in oncology risks lives. Present NCCN guidelines showing the prescribed treatment is preferred first-line and argue that step therapy allows avoidable disease progression.

Not leveraging the Express Scripts pharmacy appeal for drug denials. If the cancer drug denial came through Express Scripts, follow the pharmacy appeal process, which has separate procedures and timelines.

Draft Your Cigna Cancer Treatment Appeal with ClaimBack

Fighting a Cigna cancer denial requires presenting NCCN guidelines, molecular data, treatment urgency, and the specific discrepancies between Cigna's policy and the standard of care. ClaimBack at claimback.app generates professional appeal letters tailored to your specific Cigna cancer denial, incorporating the clinical evidence and legal arguments that maximize your chances of getting treatment authorized.

Conclusion

A Cigna cancer treatment denial demands immediate, aggressive action. With NCCN guideline support, comprehensive oncologist documentation, expedited appeal rights, and external review, cancer treatment denials are frequently overturned. Do not allow a coverage dispute to delay life-saving treatment. Start your appeal today with ClaimBack at claimback.app.

Related Reading

• Aetna Denied Cancer Treatment: Fight Back With These Steps
• AIA Singapore Denied Cancer Treatment Claim? How to Appeal
• Anthem Denied Cancer Treatment Coverage: What To Do Next
• Blue Cross Blue Shield Denied Cancer Treatment: Fight Back
• Cigna Denied Your ABA Therapy For Autism? How to Appeal